Mechanisms by which RBP4 interacts with cells are not completely understood. Results: 1300002K09Rik (RBPR2) is identified as a Stra6-related protein expressed in liver, intestine, and obese fat that mediates RBP4 binding and retinol transport. Conclusion: RBPR2 is a novel RBP4 receptor that mediates retinol uptake. Significance: RBPR2 may be important for whole body retinol homeostasis or cellular actions of RBP4 in certain tissues.
acid isomers that act as ligands for multiple nuclear hormone receptors to regulate transcription of hundreds of genes (3) (4) (5) . Nevertheless, little is known about the molecular basis of the initial step of retinol metabolism, the entry of retinol into cells. Dietary retinol is absorbed in the small intestine, and up to 90% of total body retinol is stored in liver, distributed between hepatocytes and stellate cells specialized for retinyl ester storage (6) . In addition, adipocytes can store a significant amount of retinyl esters (7) . Retinol is mobilized from liver to extrahepatic tissues by secretion of serum retinol binding protein (RBP4) into the circulation (8, 9) . RBP4 is the sole specific transport protein for retinol in blood, and nearly all circulating retinol is RBP4-bound (8, 9) . Dietary retinol deficiency results in depletion of liver retinyl ester stores, and when severe, manifests as decreased circulating RBP4 and retinol (2) . Modeling of intertissue retinol transport kinetics indicates that retinol traffics into and out of hepatocytes multiple times before finally undergoing irreversible catabolism in extrahepatic tissues (10) . Consistent with this, binding studies have revealed high affinity sites for RBP4 on hepatocyte membranes (11, 12) , and hepatocytes efficiently take up RBP4-bound retinol (13, 14) . However, circulating RBP4 is not internalized by liver, and does not appear to mediate secretion (or re-secretion) of retinol from liver (15) .
Discovery of a high affinity RBP4 receptor, Stra6, provided new insight into the molecular basis of RBP4-dependent retinol transport (16) . Stra6 is a multi-transmembrane domain protein that mediates binding of RBP4 to cell membranes and transfer of retinol from RBP4 to cells (16, 17) . Stra6 is highly conserved among mammals and other vertebrates. Stra6 is expressed in several tissues, including retina, brain, testis, muscle, and placental endothelial cells, but not in liver or intestine (16, 18) . This tissue distribution suggests an important role for Stra6 in "directional delivery" of RBP4-bound retinol from liver to extra-hepatic tissues, or as in the case of placenta, in directional delivery to the developing fetus. The physiological importance of Stra6 in development has been confirmed by its identification as the causal gene in Human Micro-ophthalmic Syndrome 9 (HMS9, encompassing Mathew-Wood Syndrome and PDAC (19) (20) (21) ). HMS9 is a congenital complex of micro-ophthalmia, mental retardation, and severe pulmonary, diaphragmatic, gastrointestinal, and in some cases, pancreatic malformations (22, 23) ; these specific anomalies are consistent with the established role of retinoic acid in organogenesis, embryonic patterning, and limb and nervous system development (24) (25) (26) (27) . HMS9 results from homozygous missense or truncating mutations of Stra6 that disrupt RBP4-binding and retinol transport or destabilize the protein (21) .
While Stra6 plays an important role in multiple tissues during development, it is not normally expressed in adult intestine or liver (16, 18) , the tissues that mediate uptake, storage, and distribution of retinol in the body. Therefore, Stra6 may not play an important role in total body retinol homeostasis. High affinity RPB4-binding and retinol uptake in liver and other cell types not expressing Stra6 imply the existence of a second RBP4 receptor/retinol transporter. Here we report that 1300002K09Rik, a gene with previously unknown function, encodes a novel retinol transporter and RBP4 receptor. We have designated this gene RBP4 Receptor-2 (RBPR2). RBPR2 is expressed primarily in liver and small intestine, and is induced in adipocytes of obese mice. Our findings identify a potentially important new mechanism for RBP4-dependent retinol transport and other cellular actions of RBP4.
EXPERIMENTAL PROCEDURES
Survey of mouse transcriptome for Stra6-related proteins-The mouse Stra6 open reading frame amino acid sequence was used to perform an unbiased query of the non-redundant nucleotide database collection of the NIH National Center for Biotechnology Information, using the phylogenybased search engine of the Laboratoire d'Informatique, de Robotiqueonly 17.8% overall homology to 1300002K09, and hence could not be detected by Basic Local Alignment Search Tool (BLAST) queries, even when employing algorithms designed to detect proteins with only partial conservation. 5'-and 3'-RACE cloning of human RBPR-The U.C. Santa Cruz Genome Browser was used to identify open reading frames potentially encoding a human RBPR2 orthologue in the human genome. Potential open reading frames were found at two distinct loci on the long and short arms of chromosome 9 (9q and 9p). RACE PCR was used to obtain the 5ꞌ-and 3ꞌ-end sequences for isolating full-length cDNA of RBPR2 sequences in the human genome. Human liver Marathon-ready cDNA (Clontech) was used as template and RACE PCR was carried out with the Marathon cDNA amplification kit (Clontech), following instructions by the manufacturer. 5ꞌ-RACE and 3ꞌ-RACE were carried out using an adaptor primer (AP1) provided by the kit and RBPR2 gene-specific primers (5ꞌ-GSP and 3ꞌ-GSP, Table 1 ). The products of 3ꞌ-and 5ꞌ-RACE were purified and cloned into the pCR4-TOPO vector provided by the TOPO TA cloning kit (Invitrogen), and inserts sequenced by the core facility at the University of Utah.
Plasmids-C-terminus HA-tagged RBPR2 and Stra6 expression plasmids were generated by amplifying cDNA open reading frames of murine RBPR2 (Genecopoeia; 1300002K09Rik; NCBI accession #NM_028788.1; product #Mm11236) or human Stra6 (Genecopoeia; NCBI accession #NM_001142619; product #Z6735) into pMEX-HA (Dualsystems Biotech) with 5'-EcoRI and 3'-BamHI overhangs, and performing directional ligation into the vector; the 3' overhangs were constructed to maintain the open reading frame through the HA-tag encoded by the plasmid. Expression plasmids pM2 for untagged RBPR2 and Stra6 open reading frames were obtained commercially (Genecopoeia).
SAP-RBP4 was generated by amplifying RBP4 mRNA (without sequence encoding the secretory signal peptide) with 5'-XhoI and 3'-XbaI overhangs, and performing directional ligation into pAPTag5 (GenHunter between Exons 5-6 of the 1300002K09Rik (RBPR2) allele; the cassette contains -galactosidase (-gal) sequence with an upstream 5' splice acceptor sequence capable of producing a transcript composed of RBPR2 (exons 1-5, amino acids 1-109) fused in-frame to -gal and a 3' poly A tail after exposure of the cassette to Cre recombinase (31) . ESCs were injected into C57Alb mouse embryos to obtain chimeric progeny by the UC Davis Transgenic Mouse Core (via NIH KOMP). Male chimeras were bred with C57Alb female mice to obtain non-albino pups with potential germline transmission of the modified RBPR2 allele. Founder pups carrying modified RBPR2 were identified by genomic PCR with primers targeting the flox--GEO cassette, and bred to zona pellucida (Zp3)-Cre transgenic mice (expressing Cre in the oocyte (32)) to generate female digenic RBPR2 (floxGEO/+) , Zp3-Cre (Tg/0) mice. Female digenic mice were bred with wildtype male C57Bl6 mice to produce pups heterozygous for a Cre/loxP-recombined RPBR2 promoter-RBPR2/-gal fusion protein reporter allele (RBPR2 promoter-reporter mice). Cre/LoxP recombination was confirmed by genomic PCR using long-range PCR with primers outside the loxP-recombined region (positive for recombinant allele), and also by short range PCR with primers from within the recombined region (negative for the recombinant allele). Detection of -gal activity was performed by sacrificing heterozygous promoter-reporter mice and rapidly dissecting tissues and incubating them for 1 hr in PBS containing X-gal (Sigma). After 1 hr, tissues were transferred to PBS containing 4% parformaldehyde, 0.1% Triton X-100, and X-gal, and stored overnight at 4 deg C. Tissues were arrayed and photographed under white light. Because of reflection problems, image of brain for wildtype mice was photographed separately and merged with images of other organs using photo editing software (Fig. 4F, top panel) .
Quantitative RT-PCR (qRT-PCR)-For primary tissue studies, mRNA was isolated from 126 tissue samples from 6 FVB mice (3 male and 3 female) using TriReagent (MRC) according to the manufacturer's directions. Tissue mRNA was arrayed with a primer-probe set from Solaris (product #74152, targeting the exon 12/13 boundary; Thermo Scientific) on 384 well optical plates and 2-step qRT-PCR reactions (Qiagen) were performed and analyzed using the Applied Biosystems 7900HT Fast Real-Time PCR System. Two replicate reactions with a single RBPR2 primer-probe set and a parallel beta actin housekeeper reaction for each tissue mRNA sample were included on each plate. Comparison studies were performed for several mice with Applied Biosystems primer-probe sets (product #Mm01345317_m1, targeting exon 1/2 boundary; #Mm01345323_m1, targeting exon 8/9 boundary; #Mm01345309_m1, targeting exon 10/11 boundary; and #Mm01345316_g1, targeting the exon 17/18 boundary), producing similar results as the Solaris primer-probe set (not shown). Normalization to beta actin by delta-Ct method did not alter interpretation of the tissue expression pattern; unnormalized data are reported. For analysis of isolated adipocyte and stromovascular (SV) adipose tissue fractions, perigonadal adipose tissue was subjected to collagenase digestion and differential buoyancy centrifugation as described elsewhere (33). mRNA was immediately isolated from adipocyte and SV fractions. For cultured cells, mRNA was prepared using TriReagent, reverse transcribed using a Verso kit (Thermo Scientific), and 1 step qPCR was performed with standard reagents (Qiagen).
Western blotting-Cells were washed twice in PBS and once in hypotonic lysis buffer (HLB: 20 mM Hepes, pH 7.5, 1 mM EDTA) and resuspended in ice cold HLB supplemented with the HALT cocktail of protease and phosphatase inhibitors (Pierce). Cells were allowed to swell 15 minutes on ice and homogenized (10 strokes with a Dounce type B glass plunger set). Lysates were centrifuged 5 minutes at 500xg at 4 deg C to pellet nuclei and other insoluble material. Supernatants were transferred to fresh tubes and centrifuged 100,000xg for 1 hr to pellet total membranes. The supernatant (cytosol) was removed, and membranes were washed by resuspension in HLB and recentrifugation at 16,000xg for 20 min at 4 deg C. Wash was removed. Membranes were resuspended in 50 ul of PBS + 1% dodecyl maltoside + 20% glycerol (without HALT) and gently vortexed and diluted in 0.450 ml of PBS + 2% zwitterionic detergent ASB14 + 10% glycerol + 2 mM beta-mercaptoethanol + 1 mg/mL brain polar lipid extract. Membranes were solubilized for 30 minutes on ice and centrifuged 16,000xg for 10 minutes at 4 deg C. 25-50 g of protein were prepared for SDS-PAGE using Novex sample buffer and gels (Invitrogen) with MES-based running buffer, according to manufacturer's instructions.
Gels were transferred to Nitrocellulose (iBlot system, Invitrogen). Western blot buffers contained non-fat milk as the blocking reagent (2% milk for blocking and 1% milk for primary and secondary antibody incubations). Anti-HA antibody was obtained commercially (Sigma). Blots were visualized by HRP-catalyzed chemiluminescence and imaged/quantitated on a Genome system (SynGene). For glycosylation studies, membrane or cytosol fractions were treated for 1 hr at 25 deg C. with a mix of glycosidases (DeGlycoMx Kit; QABio) containing PNGase F, sialidase, -galactosidase, glucosaminidase, and O-glycosidase, according to manufacturer's instructions; membranes were treated with glycosidases before the ASB14-solubilization step.
Microscopy-HEK-293 cells were seeded on glass cover slips in 6 well plates and transfected with expression plasmids for C-terminus tagged HA-Stra6 or HA-RBPR2. Cells on coverslips were washed in PBS, fixed for 20 min in 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100. Blocking was performed in PBS with 1 mg/ml bovine serum albumin (Sigma). Primary and secondary antibody incubations (1:1000 dilution of anti-HA antibody, Sigma; 1:2000 of Alexa Fluor 660-conjugated anti-rabbit IgG;Invitrogen) and WGA-fluorescein incubation (1:5000 dilution; Invitrogen) were performed in the same buffer. Cover slips were mounted on slides with Prolong Gold antifade reagent containing DAPI nuclear stain (Life Technologies). Imaging was performed on a FV1000 inverted confocal scanning laser fluorescence microscope (Olympus) equipped with appropriate filters. Image analysis was performed with Fluoview software (Olympus, version 2.0). Co-localization studies were performed with Image-J open-source software (NIH).
RBP4 binding studies-Endotoxin-free recombinant mouse Holo-RBP4 was expressed in E.Coli and purified using previously described methods (34). Holo-RBP4 and Holo-RBP4/TTR complex purified from human plasma under nondenaturing conditions were obtained commercially (HyTest) . N-terminal SAP-RBP4 fusion protein was produced by transfection of HEK-293 cells in 100 mm plates with 5 g of expression plasmid pAPTAG5.
Media were assayed for immunoreactive SAP-RBP4 by anti-RBP4 Western blotting, and heat-resistant alkaline phosphatase activity was assayed by heating at 60 deg C for 20 minutes to inactivate endogenous galactosidases and measuring room-temperature X-gal cleavage activity by optical absorbance of colorimetric product. Binding of recombinant proteins was performed after washing cells two times with serum free media and incubating cells 1-2 hrs in serum-free media. Binding was performed for 1 hr at 37 deg C at indicated concentrations in serumfree media for all experiments. For binding of purified human RBP4 or RBP4/TTR complex to cells, three washes were performed in culture wells in situ, and cells were lysed in RIPA buffer. Lysates were clarified by centrifugation at 16,000xg for 10 min at 4 deg C and analyzed by SDS-PAGE and Western blotting with anti-RBP4 or anti-TTR antibodies (DAKO-Cytomation). A similar method has been used by others to detect RBP4 binding to cells (35). For binding of SAP-RBP4, cells were collected by scraping with a rubber policeman and washed by centrifugation in microtubes (1,000xg for 5 minutes to collect cell pellets) and lysed in 1% Triton-X-100. Lysates were clarified and assayed for beta-galactosidase activity using X-gal substrate (GenHunter), with known quantities of purified -galactosidase (GenHunter) as a calibrator.
Activity was expressed in galactosidase units/mg lysate protein. SAP-RBP4 binding data were further analyzed using Prism GraphPad software (Version 5). Bestfit binding curves were generated (R 2 = 0.8531 for Stra6 binding and 0.9488 for RBPR2 binding), enabling interpolation of maximum binding Bmax and estimated binding affinity constants (Kd; data not shown).
3 H-Retinol uptake studies-Apo-RBP4 was produced by stripping off retinol with butanol and di-isopropyl ether as described (36), repurified over a DEAE spin column (Sartorius), and dialyzed overnight in PBS to remove excess salt. Removal of retinol was confirmed by confirming loss of the 330 nm (retinol) absorbance scan peak (data not shown). Apo-RBP4 (100 g) was reloaded with retinol in 0.2 ml PBS by addition of by guest on September 1, 2017 http://www.jbc.org/ Downloaded from 100 M radiolabeled retinol (American Radiolabeled Chemical, Vitamin A alcohol H(N)], adjusted to 1 Ci/nmole specific activity by addition of cold retinol), and incubating 1 hr at room temperature and then overnight at 4 deg C in light-protected tubes. The mixture was centrifuged 16,000xg in a refrigerated centrifuge, and supernatant was subjected to gel filtration chromatography (Zeba Spin Columns, Pierce) to remove unbound retinol. Protein assay of RBP4 (BCA method, Sigma) and scintillation counting of 3 H-retinol were performed to obtain specific activity (typically 2,000 dpm/pmole protein). Quality of the 3 H-retinol-bound Holo-RBP4 was confirmed by reassessing 280 nm and 330 nm absorbance scan peaks (37-39), which were approximately equal (data not shown), indicating RBP4 bound retinol in a 1:1 molar ratio based on reported molar extinction coefficients for RBP4 and retinol. The ability of the Holo-RBP4 to bind immobilized transthyretin (34) also remained intact (data not shown). A similar method was used to produce 3 H-retinol-bound albumin, except that stripping was not necessary since commercially available fatty acid-free BSA (Desert Biologicals) was used. Albumin bound less retinol (280 nm to 330 nm peak absorbance ratio of 0.81:1, indicating a molar binding ratio of ~0.72 based on molar extinction coefficients for BSA and retinol; data not shown), and so the specific activity of the retinol bound to BSA was adjusted empirically to match that of Holo-RBP4. Cells were washed twice and incubated for 1 hr in serum free media, at which point 3 H-retinol-bound RBP4 was added for 30 minutes; cells were washed three times in PBS and lysed in PBS+1% NP-40. Lysates were homogenized and transferred to scintillation tubes for scintillation counting. Lysates were clarified by centrifugation at 16,000 xg for 10 minutes, and protein assay was performed (BCA method; Sigma).
In separate experiments, a shorter timecourse of retinol uptake from Holo-RBP4 was similarly tested (2-15 minutes, at a concentration of 100 nM).
Retinol and retinyl ester measurements-Liver for retinoid measurements was rapidly frozen in liquid N 2 and stored at -80 degrees C protected from light. Frozen liver was pulverized and homogenized in a liquid N 2 -cooled mortar/pestle, and ~30 mg of tissue powder transferred to microtubes containing acid-washed ceramic disruptor beads and 500 l of PBS. 500 l EtOH containing 0.1% butylated hydroxytoluene was added, and the mixture was beadhomogenized. Homogenates were transferred to glass tubes and 1 ml of 0.025M KOH in EtOH and 10 l of 2 mM retinyl acetate standard in EtOH were added and vortexed.
10 ml hexane was added, the mixture vortexed vigorously, and then centrifuged at 1200 RPM in a clinical centrifuge for 3 minutes at room temperature. The hexane (top phase) was transferred a fresh glass tube and dried under N 2 without heat. The sample was resuspended in 0.6 ml of acetonitrile, and 100 l and 10 l injections over a Zorbax SB-C18 reverse phase column (Agilent), were performed on an Agilent 1100 quaternary pump HPLC system, by applying multiple linear solvent gradients and diode array UV absorbance detection as described by Napoli et. al. (40) . 325 nm UV absorbance peaks were quantified. Sample duplicates (100 l and 10 l injections) were compared to ensure retinyl ester peaks did not exceed the detector linear range. The retinyl acetate internal standard (peak elution at 10.2-10.6 minutes) was used to quantify amounts of retinyl esters (peak elution at 16.5-17 minutes) and retinol (peak elution at 4.7-5.2 minutes), as described (40). Two biological replicates (separate aliquots of liver) were analyzed for each mouse and averaged. Replicates with >10% variation were re-analyzed. All extractions and studies were performed in reduced light (semidark room) before solvent extraction of tissues; after extraction, all studies, including HPLC, were performed in a dark room under dim red filtered light (>600 nm).
Statistical analysis-Student's t-test (two tailed) was performed for group-wise comparisons for sample size (n) > 4 and where data were normally distributed. For sample size (n) ≤ 4 or for non-normally distributed data, the MannWhitney U test was performed.
Pearson correlation and two way ANOVA were performed with Prism 5 (GraphPad Software). P value < 0.05 was considered significant for all tests.
RESULTS
Identification of a putative retinol transporter and RBP4 receptor, RBPR2, with short regions of homology to Stra6-Because liver and other tissues without Stra6 demonstrate high affinity RBP4-binding and retinol uptake (11) (12) (13) , we considered the possibility of an unidentified RBP4 receptor and retinol transporter in those tissues. Stra6 is reported to be a unique protein in a "family unto its own" (41). Nevertheless, we reasoned that other retinol transporters may share some structural similarity with Stra6 despite lacking overall homology. We therefore employed an unbiased phylogenetic search strategy to identify transcripts with relatively weak but conserved homology to Stra6. Mouse gene 1300002K09Rik, containing several short amino acid segments with >50% amino acid homology to Stra6 (but < 18% overall amino acid homology; Fig. 1 ), was identified and further studied. We subsequently refer to this gene and its orthologues as RBP4 Receptor-2, or RBPR2. Alignment of mouse RBPR2 and Stra6 amino acid sequences reveals unexpected structural similarities.
RBPR2 is predicted to have a molecular weight of 70.1 kDa and 9-11 transmembrane domains like Stra6 (73.8 kDa) (16, 17) , with similar spacing of the transmembrane domains (Figs. 1 and 2A; Table 2 ). In addition, both proteins have predicted intracellular Cterminal soluble domains containing 74-75 amino acids (Table 2) . Remarkably, five of six amino acids affected by missense mutations in HMS9 (20, 21) are conserved in the alignment of Stra6 with RBPR2, suggesting analogous roles for these residues in the function or structural integrity of the two proteins (Figs. 1 and 2A; Table 2 ). RBPR2 lacks the canonical SH2 domain present in the Stra6 C-terminus (YTLL, a.a. 643-646 (16)), but displays a conserved threonine corresponding to the T644M HMS9 mutation (20) within the Stra6 SH2 domain (Figs. 1 and 2A; Table 2 ).
Novel, unannotated human orthologues of RBPR2-RBPR2 is highly conserved throughout vertebrate species, including primates. The mouse RBPR2 gene shares similar exon/intron organization with mouse and human Stra6 (not shown). However, in humans and other primates, open reading frames corresponding to mouse RBPR2 are found to exist as separate sets of exons within separate genes located in regions of human chromosomes 9p and 9q syntenic to the RBPR2 locus at mouse chromosome 4B1 (Fig. 2B) . The 9q gene product (which we designate RBPR2 Human Homolog Chain B) is highly homologous to the Cterminal 70% of mouse RBPR2 and has a predicted molecular weight of 48.3 kDa; whereas the 9p gene product (RBPR2 Human Homolog Chain A) is highly homologous to the N-terminal 30% of mouse RBPR2 and has a predicted molecular weight of 18.8 kDa (Figs. 1 and 2) .
RBPR2 membrane localization-To determine the subcellular localization of RBPR2 we transfected HEK-293 cells with plasmids expressing HA epitope-tagged mouse RBPR2 (HA-RBPR2) or Stra6 (HA-Stra6) for comparison. RBPR2 and Stra6 were detected by immunofluorescence confocal microscopy (Fig.  3A, top panels) . A membrane-specific fluorescent label (fluorescein-wheat germ agglutinin (WGA); Fig. 3A , middle panels) co-localized with RBPR2 and Stra6 (Fig 3A, bottom panels) in the plasma membrane, and also co-localized with RBPR2 in the Golgi region ( Fig. 3B; arrows) . Both proteins displayed some higher molecular weight laddering (Fig. 3B ., Lanes 1 and 3; asterisk).
HA-RBPR2 additionally displayed prominent lower molecular weight (40-50 kDa) bands that appear to be C-terminus proteolytic products ( Fig. 3B ; Lane 5; bracket labeled RBPR2'). Membrane fractions treated in vitro with a cocktail of endoglycosidases exhibited reduced higher molecular weight laddering (Fig.  3B , Lanes 5 and 7), indicating each protein is glycosylated to some extent.
Interestingly, endoglycosidase treatment of the RBPR2 membrane fraction increased the amount of ~45 kDa RBPR2 C-terminus proteolytic fragment detected by Western blotting (Fig. 3B, Lane 5) . Hence, glycosylation state could play a role in regulating RBPR2 stability or susceptibility to proteolytic cleavage.
RBPR2 tissue expression pattern-To determine the tissue distribution of RBPR2, we measured RBPR2 mRNA in a survey of normal mouse tissues. RBPR2 mRNA is most highly by guest on September 1, 2017 http://www.jbc.org/ Downloaded from expressed in liver, followed by small intestine, including the jejunum and ileum regions involved in dietary retinol absorption (Fig. 4A ). Spleen exhibits a smaller but significantly increased amount of RBPR2 expression (Fig. 4A) . In other tissues, including adipose tissue and isolated adipocytes, RBPR2 mRNA is near the limit of detection for qRT-PCR (C t values 35-40; relative expression shown in Fig. 4A) . A similar pattern of RBPR2 tissue expression was observed in a survey of tissues obtained from wildtype male C57Bl6 mice (data not shown). Interestingly, RBPR2 mRNA is increased in adipose tissue of two different obese mouse models: C57Bl6 mice fed high fat diet (Fig. 4B ) and leptin-deficient ob/ob mice (Fig. 4C) . Within obese adipose tissue, RBPR2 mRNA is increased in both isolated adipocytes and stromovascular cells (Fig. 4D) . Since the stromovascular fraction is enriched in vascular cells, this observation suggests that RBPR2, like Stra6, might be expressed in the vascular endothelium of certain tissues. In addition, it is possible that RBPR2 is expressed in non-vascular components such as stromal macrophages, the presence of which are known to increase in the setting of obesity and insulin resistance. Consistent with a potential role in obesity, RBPR2 mRNA is induced in late stages of 3T3L1 pre-adipocyte to adipocyte differentiation (Fig. 4E) . Because we lack antibodies that can quantify in vivo tissue expression of RBPR2 protein, we studied expression of a RBPR2--galactosidase (-gal) fusion protein under the control of the endogenous RPBR2 promoter in transgenic "promoter-reporter" mice. This model confirmed high level expression of RBPR2 in liver (Fig. 4F) . Intestine or adipose expression of RBPR2 could not be confirmed in this model due to significant endogenous galactosidase activity in those tissues (shown for wild-type adipose in Fig.  4F ). Together these findings indicate that RBPR2 is most highly expressed in liver and intestine, and strongly induced in obese adipose tissue. Because these tissues mediate uptake, storage, and distribution of retinol, these findings suggest that RBPR2 could play a physiologically relevant role in whole body retinol homeostasis.
RBP4 binding to RBPR2-Despite low amino acid homology, RBPR2 shares considerable structural similarity with Stra6, and therefore potentially binds circulating RBP4. We tested whether transfection of RBPR2 in HEK-293 cells confers increased binding of purified RBP4 or RBP4/TTR complex. HEK-293 were selected for these studies because they were reported to exhibit low RBP4-dependent retinol transport in prior studies (16) ; in addition, we do not detect significant expression of Stra6 or RBPR2 in this line, and secreted endogenous RBP4 is not detected in cell-conditioned media (data not shown). RBP4 circulates as a 1:1 complex with transthyretin (TTR) at concentrations of 0.5-2 M in normal mice and humans (9) . In controltransfected cells incubated with purified RBP4 (500 nM) there was no detectable binding of RBP4 (Fig. 5A) , whereas in cells transfected with RBPR2 or Stra6, RBP4 binding was detected over a range of concentrations (50-500 nM; Fig. 5A ). Incubating cells with purified RBP4/TTR complex produced similar results (Fig. 5B, top panel) , and TTR paralleled RBP4 binding (Fig. 5B , uppermiddle panel). Purified TTR alone exhibited some non-specific binding activity in control plasmidtransfected cells (Fig. 5C, Lane 2) ; however, there was no significant increase in binding in HA-RBPR2-transfected cells (Fig. 5C , Lanes 8 and 9 vs. Lane 2). In contrast, cells transected with HAStra6 or HA-RBPR2 and incubated with RBP4/TTR complex exhibited increased, dosedependent binding of TTR (Fig. 5C, Lanes 4-7) . Together these data indicate that RBP4/TTR complex binding is mediated by RBP4-RBPR2 interactions rather than TTR-RBPR2 interactions.
To better assess binding affinity, we used recombinant RBP4-secreted alkaline phosphatase fusion protein (SAP-RBP4). This method can detect RBP4 binding at low nanomolar concentrations (16) .
Concentration-dependent SAP-RBP4 binding was observed in cells expressing HA-RBPR2 or HA-Stra6 (Fig. 5D) . Background SAP-RBP4 binding was very low (5-7% of levels observed for HA-RBPR2) in control plasmid-transfected cells or cells transfected with leptin receptor long form (ObRb), an irrelevant receptor negative control (Fig. 5D) . Calculated binding affinities (K d ) of SAP-RBP4 for HA-Stra6 and HA-RBPR2 were 44.4 ± 17.6 nM and 52.6 ± 14.9 nM, respectively. Bovine Stra6 was previously reported to bind SAP-RBP4 with K d of 59 nM in transfected COS1 cells (16) . Amounts of total HA-RBPR2 and HA-Stra6 detected in membrane preparations by anti-HA Western blotting were similar (Fig. 5D, inset) . However, there was more total RBP4 binding observed for Stra6 than for RBPR2 at each concentration (Fig.  5D) , suggesting a greater percentage of Stra6 sites may be functional in this model. These data indicate that RBPR2 binds RBP4 -alone or in complex with TTR-with affinity comparable to that of Stra6.
Binding of RBP4 was non-covalent and peripheral to the membrane (i.e., not associated with endocytosis), since treatment of intact cells with sodium bicarbonate at pH 10 followed by washing in PBS eliminated bound RBP4 (Fig. 6A) . As expected, RBP4 binding correlated with the amount of RBPR2 expression plasmid used in transfections (Fig. 6B) , and there was no increase of RBP4 binding to cells transfected with HAtagged membrane proteins other than Stra6 and RBPR2 ( Fig. 6C and 6D ).
RBPR2-mediated retinol uptake from Holo-RBP4-In order to determine whether RBPR2 shares the retinol transport function of Stra6, we studied uptake of 3 H-retinol in RBPR2-transfected HEK-293 cells. Cells transfected with HA-Stra6 (Fig. 7A -left panel) or HA-RBPR2 (Fig. 7A -right (16) . Increased uptake of retinol by RBPR2 could be detected within 10 minutes of incubation with Holo-RBP4 (Fig. 7B) .
Cotransfection of the retinol esterifying enzyme, LRAT, increased uptake by both Stra6 and RBPR2 in comparison to cells transfected with either receptor alone (Fig. 7A, closed squares vs. open  squares) . However, LRAT alone did not increase retinol uptake in the absence of receptor expression (Fig. 7A, closed circles) . Uptake of albuminbound 3 H-retinol was low (4.4-5.5% of maximal values) in HA-Stra6 or HA-RBPR2-transfected cells (Fig. 7A, closed triangles) , indicating retinol transport favors specific RBP4-receptor interactions, as reported by others (16, 42, 43) . Together these data indicate RBPR2 functions as an RBP4-dependent retinol transporter like Stra6. In addition, while LRAT alone does not catalyze retinol uptake, it does act cooperatively with RBPR2 to enhance the intracellular accumulation of retinol. These observations suggest RBPR2 could mediate retinol uptake and storage in liver, where endogenous LRAT is highly expressed.
Endogenous RBPR2 knock down in cultured hepatocytes-To study endogenous RBPR2 regulation and function we made use of hepatoma cell lines H4IIe (rat) and Hepa1 (mouse) that express endogenous RBPR2 at levels comparable to liver; in addition, Stra6 expression in these cell lines (as in liver) is near the limits of detection based on absolute C t values of qRTPCR curves (data not shown). Each of these cell types also express endogenous RBP4, though at levels much lower than in liver such that accumulation of secreted RBP4 protein is not detected in culture media by Western blotting (data not shown). H4IIe cells express LRAT at levels comparable to liver whereas Hepa1 cells express much lower levels of LRAT (data not shown); even so, both cell types exhibit rates of retinol uptake similar to isolated primary hepatocytes studied ex vivo (14, 44, 45) . To determine whether RBPR2 is required for normal retinol transport in hepatocytes, we studied the effect of siRNAmediated knock down of RBPR2 in H4IIe. Transfection of RBPR2-specific siRNA but not non-targeting control (NTC) siRNA resulted in >80% knock down of RBPR2 mRNA (Fig. 8A) . RBPR2 knock down decreased binding of SAP-RBP4 by 48% (Fig. 8B) and decreased 3 H-retinol uptake from Holo-RBP4 (Fig. 8C ) by 73%. These findings indicate RBPR2 may be an important mediator of RBP4 binding and RBP4-dependent retinol uptake in hepatocytes. In addition, the persistence of retinol uptake after efficient knockdown of RBPR2 suggests that other receptors or mechanisms could mediate some fraction of retinol transport in these cells.
Regulation of RBPR2 expression and relation to liver retinol stores-To determine whether RBPR2 expression is associated with retinol homeostasis in liver in vivo, we compared RBPR2 mRNA to retinol and retinyl ester content in livers of normal adult mice (6-7 months of age) fed chow containing 15 IU/gm retinol. RBPR2 mRNA correlated inversely with liver total retinol content (retinol plus retinyl esters) across the range of observed values (Fig. 9A) . Since RBPR2 mediates cellular uptake of retinol from Holo-RBPR2, this finding could indicate RBPR2 expression is negatively coupled to intracellular retinol/retinoic acid. Several important regulators In addition, the proximal promoter of RBPR2 contains a conserved DR2 retinoic acid response element (at -685 base pairs from start) that may confer regulation by retinoic acid (50). To determine whether retinoids regulate RBPR2 expression, we treated mouse Hepa1 cultured hepatocytes overnight with equal amounts of Holo-RBP4 or free retinol; both treatments caused dose-dependent reductions in RBPR2 mRNA (Fig. 9B) . The treatments did not appear to induce toxicity as they did not significantly alter cell adherence, cellular protein content, or expression of individual housekeeping genes (not shown). To determine whether metabolism of retinol to retinoic acid mediates these effects, we treated Hepa1 cells with all-trans retinoic acid (ATRA) under conditions of normal (10%) or reduced (0.2%) fetal bovine serum. ATRA strongly suppressed RBPR2 mRNA under both serum conditions (Fig. 9C ). In addition, RBPR2 expression was decreased 77% in media with reduced fetal bovine serum indicating serum factors other than retinol, potentially growth factors, additionally regulate RBPR2 expression (Fig 9C) . To determine if suppression of RBPR2 by retinoids could alter retinol uptake in Hepa1, we measured uptake of 3 H-retinol from Holo-RBP4 in cells pre-treated with retinol or retinoic acid; both treatments suppressed 3 H-retinol uptake (Fig. 9D ). Together, these findings suggest the possible existence of a short-loop negative feedback mechanism by which increased availability of exogenous retinol might downregulate RBPR2 mRNA in a retinoic acid-dependent manner.
DISCUSSION
Liver has been recognized as the primary site of retinol storage in the body since the discovery of Vitamin A in the early twentieth century (1,51,52). However, the molecular basis of retinol transport in liver has remained elusive. We now report discovery of RBPR2, a retinol transporter and high affinity RBP4 receptor expressed highly in liver.
RBPR2 is also expressed in intestine, suggesting a potential role in dietary retinol absorption. In addition, RBPR2 is induced during adipocyte differentiation, and RBPR2 mRNA is increased in adipose tissue in obesity. RBPR2 shares structural homology with Stra6, and exhibits comparable RBP4-binding and retinol uptake kinetics. Therefore, RBPR2 appears to be a previously unrecognized member of the Stra6 family.
RBPR2 and Stra6 differ in several ways. RBPR2 and Stra6 exhibit fundamentally different patterns of tissue expression.
Stra6 is not expressed in liver or intestine (16, 18) , tissues where RBPR2 is most highly expressed. RBPR2 lacks the Stra6 C-terminus SH2 domain recently found to mediate RBP4-dependent Jak-STAT signaling in certain cell types (53,54). It remains to be determined whether RBP4 binding to RBPR2 can activate signaling in the absence of an intact SH2 domain. Retinoic acid (RA) suppresses RBPR2 and upregulates Stra6 (55, 56) . Since RA production is in part controlled by retinol availability, opposite regulation of the two proteins by RA could be a mechanism for directing RBP4 or retinol flux as needed either to liver (expressing RBPR2 when circulating RBP4/retinol or intracellular RA are low) or to extra-hepatic tissues (expressing Stra6 when RBP4/retinol/RA are high). Consistent with that possibility, compartmental modeling of retinol delivery in humans has shown utilization/metabolism of retinol is greatest when liver retinol stores and circulating Holo-RBP4 concentrations are high (57) . Future studies are needed to determine whether inverse regulation of RBPR2 and Stra6 by RA plays a role in coordinating in vivo retinol homeostasis.
RBPR2 is highly conserved in vertebrates, including mammals.
In humans and other primates, RBPR2 appears to have evolved as two separate genes: exons encoding a longer "Chain B" are located on 9q and contain open reading frame corresponding to the C-terminus 70% of the mouse protein, while exons encoding a shorter "Chain A" are located on 9p and contain open reading frame corresponding to the N-terminus 30% of the mouse protein (Fig. 2B) . Each of these regions of human chromsome 9 is syntenic with mouse chromosome 4B1. Several of the nearest genes located centromeric to RBPR2 on mouse 4B1 are also present in tandem with the RBPR2 Chain A gene on human 9p (Aldh1b, Igfbpl1, Shb, Mcart1), indicating the RBPR2 locus was itself the breakpoint for a chromosomal inversion during primate evolution (Fig. 2B) . Interestingly, mouse RBPR2 expressed in HEK-293 cells exhibits a distinct C-terminus ~45 kDa proteolytic product on Western blotting that is increased by endoglycosidase treatment (Fig. 3B, lane 5) , suggesting that under some conditions RBPR2 may undergo proteolysis to produce a fragment similar in size to the predicted human RBPR2 Chain B protein (48.3 kDa). Additional studies are needed to determine the extent to which human RBPR2 Chains A and B may be co-regulated, whether the chains interact to assemble a functional retinol transporter and RBP4 receptor, and whether the mouse RBPR2 protein undergoes regulated posttranslational processing by proteolysis.
These studies have limitations. We have attempted to develop several different polyclonal antibodies to RBPR2, but have not produced an antibody that reliably detects RBPR2 protein in endogenous tissues. Transfected HA-RBPR2 is highly insoluble (like Stra6) and requires use of zwitterionic detergents and phospholipids for solubilization from membranes of transfected cells (Experimental Procedures). Antibody design and solubilization methods for primary tissues will require optimization before we can accurately determine endogenous RBP4 protein expression by Western blotting. Nevertheless, we are able to confirm high level expression of a RBPR2-alkaline phosphatase fusion protein in liver of RBPR2 promoter-reporter mice, confirming qRT-PCR findings that RBPR2 expression is highest in liver. Consistent with this, RBPR2 mRNA is detected in H4IIe and Hepa1 hepatoma cells, lines known to express markers of differentiated hepatocytes (58, 59) . In addition, the diffuse pattern of -gal expression in intact liver of RBPR2 promoterreporter mice suggests hepatocytes, which make up 80% of liver by mass (60) , are the principal cell type in which RBPR2 is expressed. However, it remains possible that other liver cell types, including stellate cells, ductal cells, endothelial cells, and Kupffer cells express RBPR2. Stellate cells play a particularly important role in liver retinol homeostasis, since they store the majority of retinyl esters in neutral lipid droplets (61, 62) . The process by which retinol is transferred between stellate cells and hepatocytes is not well defined, and future studies are needed to determine if RBPR2 plays a role.
The inverse relationship between liver retinol stores and RBPR2 expression (Fig. 9A) (1), much information may be gained in the future through use of in vivo models for studying tissuespecific expression or genetic deletion of RBPR2. Toward that end, we are engineering mice with a Cre/loxP conditional allele of RBPR2.
We did not study all possible functions of RBPR2 that may exist by analogy to Stra6. For instance, it recently has been proposed that Stra6 functions as a bidirectional transporter to mediate release of retinol under certain conditions (63, 64) ; hence RBPR2 might similarly mediate bidirectional shuttling of retinol between different cell types in liver or in other tissues. Consistent with this possibility, it appears that LRAT expression is required to drive Stra6-mediated retinol transport directionally toward uptake rather than efflux in certain tissues in vivo (65). Future studies are needed to determine whether RBPR2 binds Apo-RBP4 or mediates retinol "reverse transport", and whether RBPR2 similarly requires LRAT for uptake of retinol in vivo.
In addition to its important role in retinol transport, RBP4 has been implicated in the pathogenesis of diseases associated with insulin resistance (34). Circulating RBP4 is increased in obesity, Metabolic Syndrome, and Type 2 diabetes, and excess RBP4 produced by adipocytes may play a causal role in the pathogenesis of Type 2 diabetes (66) (67) (68) (69) (70) (71) (72) (73) (74) . Injection of mice with purified Holo-RBP4 causes insulin resistance and glucose intolerance, in part through induction of liver PEPCK, a rate controlling enzyme of gluconeogenesis (34).
Treatment of cultured hepatocytes, 3T3L1 adipocytes, and isolated primary adipocytes with purified RBP4 also causes insulin resistance via regulation of several intracellular signaling pathways (34,53,75). Our findings raise the possibility that RBPR2, in the capacity of RBP4 receptor, mediates effects of RBP4 on insulin action and glucose homeostasis. In addition, the strong induction of RBPR2 Kawaguchi, R., Yu, J., Ter-Stepanian, M., Zhong, M., Cheng, G., Yuan, Q., Jin, M., Travis, G. --CCATCCTAATACGACTCACTATAGGGC GSP -Gene-specific primers corresponding to exonic sequences at 9p and 9q loci; AP1 -Adaptor primer 1. Table 2 Conservation of structure in Stra6 and RBPR2
Table abbreviations: a.a., amino acids; M.W., Molecular Weight; TMD, predicted transmembrane domain; HMS9 site, amino acid residues affected by missense mutations causing Stra6 loss of function in human microophthalmic syndrome 9; RBP4 Binding, experimentally determined region of Stra6 involved in RBP4 binding (16, 17) ; SH2, Src homology 2 domain; C-term, carboxyl terminus. *Predicted TMD10 and TMD11 of Stra6 may be part of an extended intracellular hydrophobic domain based on mapping studies by Kawaguchi et. al. (17) ; according to that model, Stra6 and RBPR2 potentially have 9 actual transmembrane domains. Five different commercial primer/probe sets were tested with similar results (Solaris assay results are shown). 8-9 week old male and female mice (n=3 for each gender) were sacrificed in the early morning fed state. Relative expression of RBPR2 was determined separately for individual tissues and normalized to liver, which was assigned relative units (RU) equal to 100; bar is average ± S.E.M. of relative expression for 6 mice; except for ovary, testis, and breast (n=3 of male or female gender). Similar results were obtained using two other commercial primer/probe sets (Applied Biosystems, not shown). Where indicated, cells were additionally co-transfected with an expression plasmid for lecithin-retinol acyl transferase (LRAT; left and right panels), the intracellular enzyme that produces the retinyl ester storage form of retinol. Intact cells were incubated for 30 minutes at 37 deg. C in serum free media containing purified recombinant murine RBP4 or fatty acid free bovine serum albumin (a non-specific ligand control) loaded with 3 H-Retinol. X-axis is concentration of either retinol-bound RBP4 or retinolbound albumin. Cells were washed, lysed, and retinol uptake determined by scintillation counting (expressed as fmol per mg cell lysate protein per min). **P < 0.01 for indicated comparisons as determined by two way ANOVA. Inset panel shows Western blot of HA-tagged receptors in membrane preparations of cells transfected in parallel. B. H4IIe rat hepatoma cells were treated with a siRNA pool designed to knock down RBPR2 or a nontargeting control siRNA pool (NTC). Effects of siRNAs were compared to treated control cells that did not receive siRNA (Mock). A. RBPR2 knock down was confirmed by measuring RBPR2 mRNA levels by qRT-PCR (Solaris). **P < 0.01 for indicated comparison. B. Binding of SAP-RBP4 at the indicated concentrations was measured in control plasmid-transfected cells and cells transfected with RBPR2 siRNA or NTC siRNA, as described in Fig. 5D and Experimental Procedures. **P < 0.01 for indicated comparison by two way ANOVA. C.
3 H-Retinol uptake was measured in Mock transfected cells and cells transfected with RBPR2 siRNA or NTC siRNA, as described in Fig. 7A and Experimental Procedures. *P < 0.05 for indicated comparison. For A, three biological replicates were measured for each condition; data are representative of two repeated experiments. For B and C, 6 biological replicates were measured in data combined from two repeated experiments. Figure 9 . Liver RBPR2 expression in vivo and regulation of RBPR2 mRNA by retinol and retinoic acid. A. RBPR2 mRNA was measured by qRT-PCR targeting the exon 10/11 junction (Solaris) in liver of wildtype C57Bl6 mice (n=7, males, age 6-7 months). Retinol and retinyl ester (ROH+RE) were measured in parallel by HPLC in aliquots of the same liver samples and averages correlated; R is the Pearson correlation co-efficient. A two-tailed P value was calculated. Correlation with ROH+RE was also obtained (R = 0.77, P < 0.05; data not shown) for qRT-PCR targeting the exon 1/2 junction (Applied Biosystems). B. RBPR2 mRNA was measured in Hepa1 mouse hepatoma cells treated overnight in reduced-serum (0.2% FBS) media containing indicated concentrations of human Holo-RBP4 or equimolar free retinol added directly to the media. *P < 0.05 or **P < 0.01 vs. vehicle-treated control. C. RBPR2 mRNA was measured in Hepa1 cells treated overnight with indicated concentrations of all-trans retinoic acid (ATRA) in media containing normal or reduced serum (10% or 0.2% FBS, respectively). **P < 0.01 for indicated comparisons; 3 biological replicates were measured. For B & C, RBPR2 was normalized to housekeeping gene GAPDH; results without normalization were comparable (not shown). D. 3 H-retinol uptake from mouse Holo-RBP4 (100 nM) was determined in cells pre-treated overnight with 1 M retinol or all-trans retinoic acid (ATRA), as described in Fig. 7A and Experimental Procedures. *P < 0.05 or **P < 0.01 vs. vehicle-treated control. 6 biological replicates were measured in data combined from two separate experiments.
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